Synprosis is specialized in the design and the synthesis of peptides and small proteins for research needs or GMP.
His expertise enables him to produce “long and / or complex” peptides:
- Polypeptides sup to 200 mer, with natural or modified amino acids
- Folding of proteins like defensins, toxins, etc…).
Synprosis is particularly active in the development of APIs for vaccines and offers various possibilities for building antigenic peptides (long linear peptides, dendrimers (MAP), conjugation to different carrier proteins, etc. ..).
To facilitate and expedite the development of your projects Synprosis proposes a “Fast track peptide drug development” protocol:
- API (from design, analytical development to the GMP production)
- Drug product (from formulation studies to the stability studies)
- Provision of first batch for clinical trial
- Technical and regulatory support